• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4619809)   Today's Articles (2986)   Subscriber (49404)
Download
Number Citation Analysis
126
Lu S, Jian H, Zhang Y, Song Z, Zhao Y, Wang P, Jiang L, Gong Y, Zhou J, Dong X, Yang N, Fang J, Zhuang W, Cang S, Ma R, Shi J, Wu P, Lu J, Xiang Z, Shi Z, Zhang L, Wang Y. OA03.07 Safety and Efficacy of D-1553 in Patients with KRAS G12C Mutated Non-Small Cell Lung Cancer: A Phase 1 Trial. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
127
Hu J, Ding N, Chen Y, Liu J, Zhou J, Xu X, Bao H, Song Y, Zhang D, Shao Y, Zhang Y. 1011P MET and NF2 alterations confer early resistance to first-line alectinib treatment in ALK-rearranged non-small cell lung cancer. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]  Open
128
Shi YK, Zhou J, Zhao Y, Zhu B, Zhang L, Li X, Fang J, Shi J, Zhuang Z, Yang S, Wang D, Yu H, Zhang L, Zheng R, Greco M, Wang T, Mo F. 981P A phase IIa study to evaluate safety and efficacy of rezivertinib (BPI-7711) in locally advanced or metastatic/recurrent treatment-naïve NSCLC patients with EGFR mutation. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]  Open
129
Wang Y, Zhang Y, Wang L, Zhang N, Xu W, Zhou J, Zhao Y, Zhu W, Zhang T, Wang L. 725P Identification of cuproptosis-related subtypes, the development of a prognosis model and drug candidates in HCC. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.849] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]  Open
130
Zhang YP, Li YW, Dai YL, Zhou J, Tu ZM, Jiang B, Wang B. Clinicopathologic and prognostic significance of long non-coding RNA myocardial infarction-associated transcript in multiple cancers. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2022;26:6129-6144. [PMID: 36111915 DOI: 10.26355/eurrev_202209_29631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
131
Wang M, Yang JH, Mitchell P, Fang J, Nian W, Chiu C, Zhou J, Zhao Y, Su WC, Camidge D, Yang TY, Zhu V, Millward M, Fan Y, Cheng Y, Jiang L, Zheng L, Jänne P. 987P Sunvozertinib for NSCLC patients with EGFR exon 20 insertion mutations: Preliminary analysis of WU-KONG6, the first pivotal study. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]  Open
132
Xu J, Zhao C, Zhou J, Luo X, Fan S, Su W, Nie K, Lin C, Yang J. 896P Multiple radiomic biomarkers-based machine learning model to predict responses of surufatinib-treated advanced neuroendocrine tumor (NET): A multicenter exploratory study. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]  Open
133
Wang L, Qin S, Zhou Y, Zhang S, Sun X, Chen Z, Cui J, Zhao P, Gu K, Li Z, Wang J, Chen X, Yao J, Shen L, Zhou J, Wang G, Bai Y, Wang Q, Wang H. LBA61 HR070803 plus 5-FU/LV versus placebo plus 5-FU/LV in second-line therapy for gemcitabine-refractory locally advanced or metastatic pancreatic cancer: A multicentered, randomized, double-blind, parallel-controlled phase III trial (HR-IRI-APC). Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.08.063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]  Open
134
Lu S, Zhang Y, Zhang G, Zhou J, Cang S, Cheng Y, Wu G, Cao P, Lv D, Jian H, Chen C, Jin X, Tian P, Wang K, Jiang G, Chen G, Chen Q, Zhao H, Ding C, Guo R, Sun G, Wang B, Jiang L, Liu Z, Fang J, Yang J, Zhuang W, Liu Y, Zhang J, Pan Y, Chen J, Yu Q, Zhao M, Cui J, Li D, Yi T, Yu Z, Yang Y, Zhang Y, Zhi X, Huang Y, Wu R, Chen L, Zang A, Cao L, Li Q, Li X, Song Y, Wang D, Zhang S. EP08.02-139 A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.822] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
135
Niu J, Amado A, Zhou J, Hebert M, Liu-Dumlao T, Capozzi M, Lindebak S. 1037P Taxol-ramucirumab-pembrolizumab (TRP) for immuno-resistant/refractory NSCLC. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]  Open
136
Sun Y, Qu W, Sun M, Zhou J, Bi X, Zhou A. 1743P ALTN-AK105-II-02 cohort 4: A phase II study of penpulimab plus anlotinib in patients (pts) with previously treated locally advanced or metastatic urothelial carcinoma (UC). Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1821] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]  Open
137
Li S, Xu S, Chen Y, Zhou J, Ben S, Guo M, Du M, Chu H, Gu D, Zhang Z, Wang M. LP-24 Thallium exposure promotes colorectal tumorigenesis via the aberrant m6A modification in ATP13A3. Toxicol Lett 2022. [DOI: 10.1016/j.toxlet.2022.07.766] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
138
Chang S, Li SS, Lu QS, Jing ZP, Zhou J. [Research progress on risk factors for adverse events after thoracic endovascular aortic repair for Stanford type B aortic dissection]. ZHONGHUA XIN XUE GUAN BING ZA ZHI 2022;50:825-829. [PMID: 35982019 DOI: 10.3760/cma.j.cn112148-20220419-00287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
139
Liu X, Huang X, Han T, Li S, Xue C, Deng J, Zhou Q, Sun Q, Zhou J. Discrimination between microcystic meningioma and atypical meningioma using whole-lesion apparent diffusion coefficient histogram analysis. Clin Radiol 2022;77:864-869. [PMID: 36030110 DOI: 10.1016/j.crad.2022.07.004] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2021] [Revised: 07/06/2022] [Accepted: 07/06/2022] [Indexed: 11/03/2022]
140
Chang S, Zhou J, Lu QS, Jing ZP. [Exploration of endovascular repair of aortic disease]. ZHONGHUA XIN XUE GUAN BING ZA ZHI 2022;50:739-742. [PMID: 35982003 DOI: 10.3760/cma.j.cn112148-20220628-00499] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
141
Jia TW, Wang W, Zhou YB, Zhou J, Mei ZQ, Li SZ. [Taxonomic rank of human parasites]. ZHONGGUO XUE XI CHONG BING FANG ZHI ZA ZHI = CHINESE JOURNAL OF SCHISTOSOMIASIS CONTROL 2022;34:420-428. [PMID: 36116936 DOI: 10.16250/j.32.1374.2021202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
142
Wang XL, Zhou MJ, Ma TY, Jiang LY, Zhao QD, Xu HB, Zhou J, Li LF, Kong L, Chen X. [Prognosis of adenoid cystic carcinoma of head and neck and risk factors for lung metastasis]. ZHONGHUA ER BI YAN HOU TOU JING WAI KE ZA ZHI = CHINESE JOURNAL OF OTORHINOLARYNGOLOGY HEAD AND NECK SURGERY 2022;57:963-968. [PMID: 36058663 DOI: 10.3760/cma.j.cn115330-20220508-00256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
143
Sun Q, Marukian N, Cheraghlou S, Paller A, Larralde M, Bercovitch L, Levinsohn J, Ren I, Hu R, Zhou J, Zaki T, Fan R, Tian C, Saraceni C, Nelson-Williams C, Loring E, Craiglow B, Milstone L, Lifton R, Boyden L, Choate K. 502 The genomic and phenotypic landscape of ichthyosis: An analysis of 1000 kindreds. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.511] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
144
Dong J, Lin P, Putra N, Tümer N, Leeflang M, Huan Z, Fratila-Apachitei L, Chang J, Zadpoor A, Zhou J. Extrusion-based additive manufacturing of Mg-Zn/bioceramic composite scaffolds. Acta Biomater 2022;151:628-646. [DOI: 10.1016/j.actbio.2022.08.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2022] [Revised: 07/09/2022] [Accepted: 08/01/2022] [Indexed: 11/01/2022]
145
Wang N, Zhang H, Ma X, Zhang J, Sun J, Wang X, Zhou J, Wang J, Ge C. Joint action of binary mixtures based on parameter k·ECx from concentration-response curves in long-term toxicity assay. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY 2022;94:103917. [PMID: 35779704 DOI: 10.1016/j.etap.2022.103917] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/28/2022] [Revised: 05/16/2022] [Accepted: 06/20/2022] [Indexed: 06/15/2023]
146
Li Q, Liu C, Ling L, Huang X, Chen S, Zhou J. [Association between coagulation function and prognosis in patients with acute pancreatitis]. NAN FANG YI KE DA XUE XUE BAO = JOURNAL OF SOUTHERN MEDICAL UNIVERSITY 2022;42:1006-1012. [PMID: 35869762 DOI: 10.12122/j.issn.1673-4254.2022.07.06] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
147
Guo ZY, Feng JX, Zhang LJ, Zhou YB, Zhou J, Yang K, Liu Y, Lin DD, Liu J, Dong Y, Wang TP, Wen LY, Ji MJ, Wu ZD, Jiang QW, Liang S, Guo J, Cao CL, Xu J, Lü S, Li SZ, Zhou XN. [Analysis of the new WHO guideline to accelerate the progress towards elimination of schistosomiasis in China]. ZHONGGUO XUE XI CHONG BING FANG ZHI ZA ZHI = CHINESE JOURNAL OF SCHISTOSOMIASIS CONTROL 2022;34:217-222. [PMID: 35896483 DOI: 10.16250/j.32.1374.2022113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
148
Xu J, Li YF, Dong Y, Zhao ZY, Wen LY, Zhang SQ, Lin DD, Zhou J, Liang S, Guo JG, Li SZ, Zhou XN. [Decoding the evolution of preventive chemotherapy schemes for schistosomiasis in China to improve the precise implementation of the WHO guideline on control and elimination of human schistosomiasis]. ZHONGGUO XUE XI CHONG BING FANG ZHI ZA ZHI = CHINESE JOURNAL OF SCHISTOSOMIASIS CONTROL 2022;34:223-229. [PMID: 35896484 DOI: 10.16250/j.32.1374.2022111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
149
Xu J, Ciren RDJ, Li X, Lei JF, Zhou J, Hou B. [Study of cross-sectional morphology of root canals in Tibetan mandibular incisors by micro-computed tomography]. ZHONGHUA KOU QIANG YI XUE ZA ZHI = ZHONGHUA KOUQIANG YIXUE ZAZHI = CHINESE JOURNAL OF STOMATOLOGY 2022;57:739-744. [PMID: 35790514 DOI: 10.3760/cma.j.cn112144-20210731-00349] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
150
Guan DX, Wu J, Zhang J, Guo S, Yu FH, Zhou J, Wang GL, Xu XW. [Clinical features and risk factors for early relapse of pediatric ulcerative colitis]. ZHONGHUA ER KE ZA ZHI = CHINESE JOURNAL OF PEDIATRICS 2022;60:660-665. [PMID: 35768353 DOI: 10.3760/cma.j.cn112140-20220401-00271] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
PrevPage 6 of 106 12567105106Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA